Curt Labelle

Curt Labelle is the Director at Alydia Health. Prior to this, they were with Maternal Newborn Health Innovations, AXA IM Global Health Fund, Z Optics, and AXA IM Prime Impact Fund. Curt also has experience in the Serum Institute and Atomo Diagnostics (ASX: AT1). Most recently, they were with Atticus Medical. Curt has dedicated their career to global health and has a wealth of experience in investment funds and diagnostics.

Curt Labelle has an MBA from Columbia Business School, an MD from Columbia University Vagelos College of Physicians and Surgeons, and a Bachelor's Degree in Economics from Brigham Young University.